These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9557781)

  • 1. Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma.
    Thewes M; Worret WI; Engst R; Ring J
    Am J Dermatopathol; 1998 Apr; 20(2):140-2. PubMed ID: 9557781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation.
    Costache M; Bresch M; Böer A
    Histopathology; 2008 Jun; 52(7):865-76. PubMed ID: 18462369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.
    Abbas O; Richards JE; Mahalingam M
    Mod Pathol; 2010 Nov; 23(11):1535-43. PubMed ID: 20711172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical study of basal cell carcinoma and trichoepithelioma.
    Poniecka AW; Alexis JB
    Am J Dermatopathol; 1999 Aug; 21(4):332-6. PubMed ID: 10446773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders.
    Thewes M; Worret WI; Engst R; Ring J
    Clin Exp Dermatol; 1999 Mar; 24(2):122-6. PubMed ID: 10233668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma?
    Mohanty SK; Sardana R; McFall M; Pradhan D; Usmani A; Jha S; Mishra SK; Sampat NY; Lobo A; Wu JM; Balzer BL; Frishberg DP
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):273-277. PubMed ID: 35384877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
    Sellheyer K; Nelson P; Kutzner H; Patel RM
    J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
    Katona TM; Perkins SM; Billings SD
    J Cutan Pathol; 2008 Feb; 35(2):174-9. PubMed ID: 18190441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10 expression in trichoepithelioma and basal cell carcinoma.
    Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
    J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms.
    Kirchmann TT; Prieto VG; Smoller BR
    J Cutan Pathol; 1995 Oct; 22(5):422-6. PubMed ID: 8594074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma.
    Verhaegh ME; Arends JW; Majoie IM; Hoekzema R; Neumann HA
    Dermatol Surg; 1997 Aug; 23(8):695-700. PubMed ID: 9256917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
    Jedrych J; McNiff JM
    Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcystic adnexal carcinoma: an immunohistochemical reappraisal.
    Hoang MP; Dresser KA; Kapur P; High WA; Mahalingam M
    Mod Pathol; 2008 Feb; 21(2):178-85. PubMed ID: 18065959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma.
    Illueca C; Monteagudo C; Revert A; Llombart-Bosch A
    J Cutan Pathol; 1998 Sep; 25(8):435-9. PubMed ID: 9826169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.
    Kirchmann TT; Prieto VG; Smoller BR
    Arch Dermatol; 1994 May; 130(5):589-92. PubMed ID: 7513986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of solitary trichoepithelioma versus basal cell carcinoma.
    Votruba M; Collins CM; Harrad RA
    Eye (Lond); 1998; 12 ( Pt 1)():43-6. PubMed ID: 9614515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ln-γ 2 chain of laminin-332 is a useful marker in differentiating between benign and malignant sclerosing adnexal neoplasms.
    Koga K; Anan T; Fukumoto T; Fujimoto M; Nabeshima K
    Histopathology; 2020 Jan; 76(2):318-324. PubMed ID: 31429981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic trichilemmoma: a case report with immunohistochemical characterization of the extracellular matrix components.
    Massi D; Franchi A
    Acta Derm Venereol; 1997 Sep; 77(5):347-9. PubMed ID: 9298125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
    Evangelista MT; North JP
    J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
    Mitcov M; Scrivener Y; Cribier B
    Ann Dermatol Venereol; 2009; 136(6-7):501-7. PubMed ID: 19560610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.